Haydar Bulut

9PUBLICATIONS
75CO-AUTHORS
Biomolecular modelling and designBiologically active moleculesMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsGenetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 02, 2026
Impact of Single Halogen Atom Substitutions on Antiviral Profile of Inhibitors Targeting SARS-CoV‑2 Main Protease.

Haydar Bulut, Nobuyo Higashi-Kuwata, Hiromi Ogata-Aoki

|Jan 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi

|Sep 05, 2024
Structural and virologic mechanism of the emergence of resistance to Mpro inhibitors in SARS-CoV-2.

Shin-Ichiro Hattori, Haydar Bulut, Hironori Hayashi

|Sep 27, 2023
Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties.

Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa

|Jul 12, 2023
GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants.

Manabu Aoki, Hiromi Aoki-Ogata, Haydar Bulut

|Feb 25, 2023
Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.

Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi

Pageof 2

Frequent Collaborators

5 joint publications

Hirokazu Tamamura

5 joint publications

Hiroaki Mitsuya

5 joint publications

Shin-Ichiro Hattori

5 joint publications

Nobuyo Higashi-Kuwata